MediPurpose

Press Release

Medical product company MediPurpose™ was recently granted patent ZL 2009 8 0130958.X for its babyLance™ safety heelstick from the State Intellectual Office of the PRC (SIPO) in Beijing, China.

Beijing, China, January 31, 2014 --(PR.com)-- MediPurpose(tm), a master distributor and manufacturer of medical products, today announced an addition to its expanding portfolio of lancet patents.

The medical product company was recently granted patent ZL 2009 8 0130958.X for its babyLance(tm) safety heelstick from the State Intellectual Office of the PRC (SIPO) in Beijing, China.

MediPurpose holds numerous international patents that protect its medical device intellectual property (IP), both for babyLance and the SurgiLance(tm) safety lancet.

"Our pursuit of medical device patents in countries around the globe is not just intended to protect our medical device IP," said MediPurpose founder and CEO Patrick Yi. "Additionally, it's an expression of our commitment to either serving the countries in which we distribute our medical products, or our intention to secure relationships with medical product distributors in them."

About babyLance(tm) Safety Heelsticks

babyLance safety heelsticks are single-use safety neonatal needlestick devices for the collection of blood from infants.

Specifically designed to meet neonatal nurses' expectations for the ideal heelstick, babyLance provides enhanced stability, comfort and ease of use.

babyLance is available in two models, each with a specific blade penetration:

Founded in 1999, MediPurpose is an innovative medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular babyLance(tm) safety heelstick, SurgiLance(tm) safety lancet and MediPlus(tm) advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.